Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01985308 · ClinicalTrials.gov registry record · NA
A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism
A NA study, sponsored by Wave Neuroscience.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT01985308: Completed NA study, sponsored by Wave Neuroscience.
NCT01985308 is a NA study that has completed, run by Wave Neuroscience. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01985308, a NA study, has completed, sponsored by Wave Neuroscience.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to show that a magnetic field applied to the front part of the brain of children suffering from Autism Spectrum Disorder(ASD) can improve function and ameliorate symptoms.
Primary Outcome
The Childhood Autism Rating Scale is a behavior rating scale that measures the severity of autism symptoms in children. It consists of 15 sub-domains including relating to people, adaptation to change, verbal communication, and visual response. Each sub-domain is rated between 1-4, with the total score ranging from a low of 15 to a high of 60. Scores below 30 indicate that the individual is in the non-autistic range. Scores between 30 and 36.5 indicate mild to moderate autism, and scores from 37
Interventions
- DEVICE Magnetic Resonance Therapy (MRT)-Active
- DEVICE Magnetic Resonance Therapy (MRT)-Sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01985308 record still lists
NCT01985308 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Therapy (MRT)-Active is the first listed.
NCT01985308 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01985308 about?
NCT01985308 is a clinical study titled "A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism". The purpose of this study is to show that a magnetic field applied to the front part of the brain of children suffering from Autism Spectrum Disorder(ASD) can improve function and ameliorate symptoms.
What is the current status of trial NCT01985308?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2013-11. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01985308?
The interventions under investigation include: Magnetic Resonance Therapy (MRT)-Active (DEVICE), Magnetic Resonance Therapy (MRT)-Sham (DEVICE).
Who is sponsoring clinical trial NCT01985308?
This trial is sponsored by Wave Neuroscience, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01985308's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia